Decipher Labs (BSE 524752)₹5.60−1.75%Pharmaceuticals
In the Jun 2026 quarter (consolidated), Decipher Labs reported sales of ₹2.42 Cr, down 16.8% from Jun 2025, and net profit of −₹2.20 Cr. For the year to Mar 2026, sales were ₹14.04 Cr and net profit −₹3.09 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7.50 | 8.30 | 10.58 | 7.43 | 5.88 | 5.79 | 3.51 | 2.91 | 4.32 | 3.22 | 3.59 | 2.42 |
| Expenses | 9.61 | 8.13 | 9.35 | 6.10 | 7.17 | 6.40 | 10.05 | 6.21 | 4.17 | 3.62 | 3.36 | 4.56 |
| Operating Profit | −2.16 | 0.12 | 1.20 | 1.30 | −1.32 | −0.62 | −6.57 | −3.31 | 0.11 | −0.42 | 0.22 | −2.15 |
| OPM % | −29.0% | 1.6% | 11.4% | 17.6% | −22.7% | −10.9% | −188.0% | −113.7% | 2.8% | −13.4% | 6.4% | −89.6% |
| Other Income | 0.15 | 0.00 | 0.28 | 0.17 | 0.13 | 0.18 | 0.88 | 0.02 | 0.03 | 0.03 | 0.18 | 0.11 |
| Interest | 0.00 | 0.00 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.10 | 0.11 | 0.10 | 0.10 | 0.11 | 0.11 | 0.12 | 0.11 | 0.12 | 0.12 | 0.14 | 0.12 |
| Profit before tax | −2.13 | 0.00 | 1.15 | 1.35 | −1.32 | −0.57 | −5.83 | −3.42 | 0.00 | −0.53 | 0.24 | −2.18 |
| Tax % | −9.4% | 0.0% | −3.5% | 30.1% | 0.0% | 1.7% | −29.7% | 0.0% | 0.0% | 1.8% | 244.0% | 0.0% |
| Net Profit | −1.95 | 0.02 | 1.21 | 0.96 | −1.34 | −0.60 | −4.13 | −3.44 | 0.03 | −0.55 | −0.37 | −2.20 |
| EPS (Rs) | −1.91 | 0.00 | 1.18 | 0.93 | −1.31 | −0.57 | −4.05 | −3.39 | 0.01 | −0.52 | −0.35 | −2.16 |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.01 | 8.05 | 23.97 | 55.57 | 65.33 | 45.56 | 35.85 | 22.62 | 14.04 | 13.55 |
| Expenses | 0.94 | 7.58 | 21.37 | 51.90 | 59.01 | 49.57 | 36.43 | 24.42 | 17.37 | 15.71 |
| Operating Profit | 0.06 | 0.44 | 2.51 | 3.47 | 6.02 | −4.16 | −0.67 | −1.88 | −3.38 | −2.24 |
| OPM % | 6.8% | 5.6% | 10.5% | 6.3% | 9.2% | −9.2% | −1.9% | −8.4% | −24.1% | −16.5% |
| Other Income | 0.12 | 0.00 | 0.28 | 0.66 | 7.71 | 0.93 | 0.17 | −4.04 | 0.23 | 0.35 |
| Interest | 0.00 | 0.00 | 0.76 | 1.16 | 0.47 | 0.47 | 0.23 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.55 | 0.81 | 0.86 | 0.42 | 0.44 | 0.47 | 0.51 | 0.50 |
| Profit before tax | 0.17 | 0.43 | 1.45 | 2.13 | 12.34 | −4.15 | −1.20 | −6.38 | −3.68 | −2.47 |
| Tax % | 0.0% | 9.1% | 25.3% | 34.6% | 7.8% | −35.6% | 38.0% | −20.5% | −16.3% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −6.02 | 0.00 | −5.02 | 0.00 | — |
| Net Profit | 0.19 | 0.42 | 1.11 | 1.41 | 11.42 | −2.69 | −1.69 | −5.10 | −3.09 | −3.09 |
| EPS (Rs) | 0.21 | 0.50 | 1.08 | 1.38 | 11.24 | −2.64 | −1.65 | −5.01 | −3.04 | −3.02 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8.00 | 7.99 | 10.07 | 10.06 | 10.06 | 10.06 | 10.06 | 10.06 | 10.06 |
| Reserves | −5.88 | −5.48 | 2.46 | 3.59 | 14.03 | 13.09 | 11.74 | 12.74 | 10.55 |
| Borrowings | 0.12 | 0.19 | 11.25 | 16.34 | 10.28 | 0.94 | 0.00 | 0.23 | 0.49 |
| Other Liabilities | 0.71 | 3.63 | 11.50 | 8.60 | 7.42 | 4.00 | 11.71 | 2.65 | 3.14 |
| Total Liabilities | 2.95 | 6.33 | 35.28 | 38.59 | 41.79 | 28.09 | 33.51 | 25.68 | 24.24 |
| Fixed Assets | 0.00 | 0.02 | 4.99 | 4.44 | 2.84 | 3.32 | 2.92 | 2.55 | 2.54 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.25 | 3.75 | 3.38 | 0.25 | 0.00 |
| Other Assets | 2.95 | 6.31 | 30.29 | 34.15 | 38.70 | 21.02 | 27.21 | 22.88 | 21.70 |
| Inventories | 0.09 | 0.31 | 0.31 | 0.03 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Trade receivables | 0.58 | 3.45 | 14.58 | 11.63 | 12.75 | 9.81 | 7.78 | 4.21 | 2.59 |
| Cash & equivalents | 0.01 | 0.29 | 1.46 | 6.97 | 15.40 | 7.41 | 9.30 | 2.80 | 0.73 |
| Total Assets | 2.95 | 6.33 | 35.28 | 38.59 | 41.79 | 28.09 | 33.51 | 25.68 | 24.24 |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −0.09 | 0.22 | −15.15 | 1.82 | 8.25 | −1.55 | 4.84 | −9.80 | −2.07 |
| Cash from investing activity | 0.00 | −0.03 | −0.02 | −0.32 | −1.14 | −4.29 | −1.80 | 3.08 | −0.25 |
| Cash from financing activity | 0.10 | 0.08 | 16.39 | 4.00 | 1.31 | −2.16 | −1.18 | 0.25 | 0.27 |
| Net cash flow | −0.02 | 0.29 | 1.18 | 5.53 | 8.46 | −8.01 | 1.91 | −6.53 | −2.08 |
| Capex | 0.00 | 0.00 | 0.23 | 0.30 | 0.19 | 0.77 | 0.05 | 0.05 | 0.23 |
| Free cash flow | −0.09 | 0.21 | −15.41 | 1.51 | 8.05 | −2.33 | 4.78 | −9.87 | −2.31 |
| CFO / OP % | −143.0% | 51.0% | −602.0% | 53.0% | 137.0% | 37.0% | −713.0% | 520.0% | 61.0% |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 210 | 156 | 221 | 76 | 70 | 78 | 78 | 67 | 67 |
| Inventory days | 91 | 20 | — | — | — | — | 0 | — | — |
| Days payable | 511 | 193 | — | — | — | — | — | — | — |
| Cash conversion cycle | −210 | −17 | 221 | 76 | 70 | 78 | 78 | 67 | 67 |
| Working capital days | 750 | 99 | −3 | −12 | 64 | 61 | 36 | 246 | 394 |
| ROCE % | — | 18.1% | 16.9% | 12.4% | 39.8% | 9.5% | −3.1% | −4.6% | −16.6% |
For the Jun 2026 quarter, Decipher Labs reported sales of ₹2.42 Cr, down 16.8% year on year and net profit of −₹2.20 Cr. The operating margin was −89.6%.
Decipher Labs' sales for the year to Mar 2026 were ₹14.04 Cr; over the last twelve months they were ₹13.55 Cr.
Net profit for the year to Mar 2026 was −₹3.09 Cr, and −₹3.09 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−3.02.
Decipher Labs reported borrowings of ₹0.49 Cr at Mar 2026, against cash and equivalents of ₹0.73 Cr.
Cash from operations was −₹2.07 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹2.31 Cr.